PEG-MGF refers to a modified mechano-growth-factor peptide, but related E-peptide studies show conflicting cell results and do not establish the behavior of an unspecified PEG conjugate.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Modified IGF-I E-peptide research
MGF terminology originates from an alternatively processed IGF-I transcript and its E-domain sequence. Synthetic MGF E-peptides are separate experimental materials from mature IGF-I and the complete precursor. PEG-MGF additionally implies attachment of polyethylene glycol. Without a defined peptide sequence, attachment site, and PEG specification, the catalog name does not identify the precise construct examined by an experiment.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Early experiments proposed that the MGF E-domain could influence muscle precursor proliferation through signaling distinguishable from the conventional IGF-I receptor pathway. Later investigators failed to reproduce those effects across several models. Consequently, a dedicated MGF receptor or consistent growth-promoting mechanism should not be treated as established for PEG-MGF.
A 2002 cell study reported that an MGF E-peptide favored myoblast proliferation while delaying differentiation, contrasting with mature IGF-I. A subsequent erratum accompanies that publication. These findings concern the parent peptide rather than a characterized PEG conjugate. [1]
A later study found no apparent MGF-peptide effect in mouse myoblasts, human skeletal-muscle myoblasts, or primary mouse muscle stem cells despite active IGF-I controls. This directly limits confidence in a broadly reproducible proliferative response. [2]
Human biopsies after exercise-related muscle damage showed changing IGF-I isoform expression. Separate cell experiments examined an E-peptide. The human component measured an endogenous response; participants were not treated with PEG-MGF. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The cited literature connects endogenous transcript biology with disputed cell findings. It does not demonstrate that a particular PEG-MGF preparation increases human muscle growth, accelerates recovery, or reproduces the actions of endogenous IGF-I variants.
Conjugation can create a materially different test article, so parent-peptide results cannot establish PEG-MGF exposure, potency, persistence, or safety. A molecularly defined construct and direct comparative experiments are needed before assigning a mechanism or interpreting a biological assay.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Parent MGF E-peptide study, with a 2006 erratum; not evidence for a defined PEG-MGF construct.
Failed replication across several muscle-cell models; native and stabilized peptides do not establish an unspecified PEG conjugate.
Human endogenous expression measurements plus separate cell experiments; no human administration of PEG-MGF.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
